Curcumin's Biomedical Applications
Curcumin's Biomedical Applications is a research topic within Molecular Medicine. Science Explorer counts 13k research works in it since 1950. 20.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the bioavailability, health effects, and therapeutic potential of curcumin, a natural compound with antioxidant, anti-inflammatory, and potential anticancer properties. The papers cover various aspects including its molecular targets, clinical trials, nanoparticle encapsulation for improved delivery, neuroprotective effects, and pharmacokinetics. The research explores the application of curcumin in the prevention and treatment of various diseases such as cancer, neurodegenerative diseases, cardiovascular diseases, and diabetes.
- Curcumin
- Bioavailability
- Antioxidant
- Inflammation
- Cancer
- Therapeutic
- Nanoparticles
- Clinical Trials
- Neuroprotective
- Pharmacokinetics
- Research works
- 13k fractional, since 1950
- In the world top 10%
- 2.7k per year above
- Top-10% rate
- 20.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +60% the tick is no change
Which countries lead Curcumin's Biomedical Applications research?
By volume, China and India publish the most (927 and 725 works in 2022–2025).
By volume, 2022–2025
- 1 China 927 works
- 2 India 725 works
- 3 Iran 357 works
- 4 Indonesia 220 works
- 5 Egypt 211 works
- 6 United States 206 works
- 7 Türkiye 122 works
- 8 Saudi Arabia 112 works
- 9 Brazil 109 works
- 10 South Korea 90 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Curcumin's Biomedical Applications research?
By volume in 2022–2025, Mashhad University of Medical Sciences publishes the most Curcumin's Biomedical Applications research, followed by Saveetha University and Cairo University.
By volume, 2022–2025
- 1 Mashhad University of Medical SciencesIran 28 works
- 2 Saveetha UniversityIndia 27 works
- 3 Cairo UniversityEgypt 26 works
- 4 King Saud UniversitySaudi Arabia 24 works
- 5 Tabriz University of Medical SciencesIran 20 works
- 6 National Research CentreEgypt 16 works
- 7 University of BrawijayaIndonesia 16 works
- 8 Airlangga UniversityIndonesia 16 works
- 9 Chengdu University of Traditional Chinese MedicineChina 15 works
- 10 Shiraz University of Medical SciencesIran 14 works
Who are the leading researchers in Curcumin's Biomedical Applications?
The most-cited researchers publishing on Curcumin's Biomedical Applications include Amirhossein Sahebkar and Bharat B. Aggarwal.
- 1 Amirhossein Sahebkar Iran 5.6k citations
- 2 Bharat B. Aggarwal United States 4.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Curcumin's Biomedical Applications research done?
The largest centres of Curcumin's Biomedical Applications research in 2022–2025 are Tehran (Iran), Beijing (China), Chennai (India) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Mashhad and Tabriz.
Largest cities, 2022–2025
Where it is the local speciality
- MashhadIR · 39.6 works18×
- TabrizIR · 38.9 works14×
Location quotient: how much more of its research is in Curcumin's Biomedical Applications than the world average.
Where is the best place to study Curcumin's Biomedical Applications?
Among universities, judged by research, Mashhad University of Medical Sciences, Tabriz University of Medical Sciences and Cairo University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Mashhad University of Medical SciencesIran | 84.9 | 28.9% | 29.6× | 28 | +726.7% |
| 2 | Tabriz University of Medical SciencesIran | 73.7 | 21.3% | 21.4× | 20 | +198.7% |
| 3 | Cairo UniversityEgypt | 71.4 | 25.7% | 8.1× | 26 | +106.6% |
| 4 | Chengdu University of Traditional Chinese MedicineChina | 64.4 | 29.1% | 17.4× | 16 | — |
| 5 | Saveetha UniversityIndia | 61.4 | 22.0% | 6.7× | 27 | — |
| 6 | King Saud UniversitySaudi Arabia | 60.4 | 18.7% | 6.6× | 24 | +8.0% |
| 7 | Tehran University of Medical SciencesIran | 57.2 | 24.0% | 6.2× | 12 | +335.1% |
| 8 | Beijing University of Chinese MedicineChina | 54.7 | 23.5% | 14.3× | 10 | +76.7% |
| 9 | Shiraz University of Medical SciencesIran | 50.4 | 11.1% | 12.9× | 14 | +57.0% |
| 10 | Tanta UniversityEgypt | 50.1 | 11.7% | 7.8× | 10 | +184.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Curcumin's Biomedical Applications research growing?
Output in 2018–2022 was 60% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Curcumin's Biomedical Applications.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.